1. Cost-Effectiveness Analysis of Six Immunotherapy-Based Regimens and Sunitinib in Metastatic Renal Cell Carcinoma: A Public Payer Perspective. Issue 3 (4th March 2023) Authors: Yoo, Minkyoung; Nelson, Richard E.; Cutshall, Zachary; Dougherty, Maura; Kohli, Manish Journal: JCO oncology practice Issue: Volume 19:Issue 3(2023) Page Start: e449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗